05.03.2013
To the attention of Marketing Authorisation Holders
Submission of the pharmacovigilance system summary for medicinal products undergoing marketing authorisation renewal through national procedure, submitted prior to 21 July 2012, is performed by means of a Type IAIN C.I.z variation.